Organon & Co
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | -6.9% | -20.5% | -16.0% | -3.5% | -2.1% | +1.4% | +2.2% | -2.9% | |
| – | +2.3% | -51.5% | -6.8% | +12.4% | -3.7% | +9.6% | +6.9% | +6.2% | |
| – | -14.0% | +8.2% | -19.8% | -11.1% | -1.1% | -3.4% | -0.9% | -9.5% | |
| – | +2.8% | -39.7% | -4.5% | +111.0% | +6.3% | +12.1% | -11.2% | -22.0% | |
| – | -12.3% | -30.2% | -1.9% | +23.7% | +1.2% | +16.2% | -7.7% | +10.7% | |
| – | -9.9% | -30.1% | -5.8% | +28.2% | +8.4% | +11.3% | -7.9% | -6.4% | |
| – | -17.3% | +42.2% | -26.0% | -32.7% | -11.0% | -22.2% | +12.0% | -13.5% | |
| – | +114.3% | -86.7% | +0.0% | +4,200.0% | +63.6% | +24.9% | -1.3% | -3.1% | |
| – | -11.9% | +35.4% | -25.5% | -44.4% | -26.6% | -40.0% | +19.9% | -47.3% | |
| – | -55.6% | -32.3% | +27.2% | -64.1% | +15.2% | -270.7% | – | – | |
| – | +19.5% | +49.5% | -32.9% | -37.5% | -32.1% | +11.6% | -15.5% | -78.4% | |
| – | -13.8% | -10.6% | -23.7% | -33.7% | -11.4% | -18.2% | +11.7% | -20.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.